Impact of SGLT2 Inhibitors in Heart Transplant Recipients
Conditions: Transplant; Failure, Heart; Cardiac Allograft Vasculopathy; Rejection Heart Transplant Interventions: Drug: SGLT2i Sponsors: Universidade Federal do Ceara; Hospital de Messejana Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2023 Category: Research Source Type: clinical trials
Efficacy and Safety of Immunosuppressive Withdrawal After Pediatric Liver Transplantation
Conditions: Immune Tolerance; Immunosuppression; Liver Transplant; Complications Interventions: Drug: Tacrolimus or Cyclosporine A Sponsors: Wei Gao Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2023 Category: Research Source Type: clinical trials
Early Conversion of Prolonged-release Tacrolimus in Liver Transplantation.
Conditions: Liver Transplantation Interventions: Drug: Tacrolimus Sustained-release Capsules Sponsors: Beijing Tsinghua Chang Gung Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2023 Category: Research Source Type: clinical trials
Treatment of Alopecic Scars by Follicular Unit Extraction Hair Transplantation
Conditions: Alopecia Scar Interventions: Procedure: follicular unit extraction and implantaion Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2023 Category: Research Source Type: clinical trials
Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Liver Transplantation Surgery
Conditions: Liver Diseases Interventions: Biological: fresh frozen plasma; Biological: prothrombin complex concentrate Sponsors: Konkuk University Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
Using Shared Decision Making to Improve Kidney Transplantation Rates
Conditions: End Stage Renal Disease; Kidney Failure Interventions: Behavioral: Provider educational materials; Behavioral: Patient letters Sponsors: Columbia University; Kidney Transplant Collaborative; National Kidney Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2023 Category: Research Source Type: clinical trials
Randomized Phase IIa Clinical Trial in Parkinson's Disease Patients Using Pluripotent Adipose Stem Cells
Conditions: Parkinson Disease Interventions: Biological: PASC transplantation (25 million PASCs/patient); Biological: Control Sponsors: ClusterXStem-Costa Rica; Universidad de Costa Rica; University of California, Los Angeles Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2023 Category: Research Source Type: clinical trials
Randomized Clinical Trial in Parkinson's Disease Patients Using Pluripotent Adipose Stem Cells (PASCs)
Conditions: Parkinson Disease Interventions: Biological: PASC transplantation (25 million PASCs/patient); Biological: Control Sponsors: ClusterXStem-Costa Rica; Universidad de Costa Rica; University of California, Los Angeles Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2023 Category: Research Source Type: clinical trials
Impact of Atelectasis on RVEDP Following Orthotropic Heart Transplantation
Conditions: Heart Transplant Failure; Anesthesia Interventions: Other: Lung Recruitment Sponsors: Baylor College of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 20, 2023 Category: Research Source Type: clinical trials
Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant Recipients
Conditions: Kidney Transplant; Complications; Vascular Diseases; Diabetes Interventions: Drug: Dapagliflozin 10mg Tab; Drug: Placebo Sponsors: University of Colorado, Denver Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 20, 2023 Category: Research Source Type: clinical trials
Liver Transplantation in Intrahepatic Cholangiocarcinoma
Conditions: Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma; Determine Efficacy of Liver Transplantation After Neoadjuvant Systemic Therapy in Patients With Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma Interventions: Procedure: Liver Transplant Sponsors: Rutgers, The State University of New Jersey Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2023 Category: Research Source Type: clinical trials
Cytokine-induced Memory-like Natural Killer Cell Therapy After Hematopoietic Stem Cell Transplantation for Eradication of Measurable Residual Disease, a Phase I/Ib Clinical Trial
Conditions: Acute Myeloid Leukemia; Leukemia; Leukemia, Myeloid; Myelodysplastic Syndromes; Myeloproliferative Neoplasm; Myeloproliferative Disorders Interventions: Biological: Cytokine Induced Memory-like Natural Killer Cells; Biological: Interleukin-2 Sponsors: Dana-Farber Cancer Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2023 Category: Research Source Type: clinical trials
Thrombopoietin Agonists in Patients With Idiopathic Thrombocytopenic Purpura
Conditions: ITP - Immune Thrombocytopenia Interventions: Drug: eltrombopag and romiplastim Sponsors: Assiut University; Association for Training, Education, and Research in Hematology, Immunology, and Transplantation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2023 Category: Research Source Type: clinical trials
Adherence, Viability, Clinical Evolution and Therapeutic Efficacy in Patients Undergoing Bone Marrow Transplantation
Conditions: Stem Cell Transplantation Interventions: Device: Cycle ergometer; Device: Strength Training - elastic band and shin guards; Device: Cycle ergometer, elastic band and shin guards Sponsors: Federal University of Health Science of Porto Alegre Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials
A Study of mRNA-1647 Cytomegalovirus Vaccine in Liver Transplant Candidates and Recipients
Conditions: Cytomegalovirus Infection Interventions: Biological: mRNA-1647; Biological: Placebo Sponsors: ModernaTX, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2023 Category: Research Source Type: clinical trials
